<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-12T12:45:29+00:00">
  <iati-activity last-updated-datetime="2026-11-11T11:05:58+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-NIC-C-REDNICA-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Nicaragua holding the achievements and consolidating the actions aimed at pre-elimination of HIV, AIDS and Tuberculosis - Nicaragua (01-Jan-2025-31-Dec-2027)</narrative>
    </title>
    <description type="1">
      <narrative>Nicaragua, TB/HIV, Federación Red NICASALUD</narrative>
    </description>
    <description type="2">
      <narrative>Goal: Maximizar los servicios de salud integrados y centrados en las personas con el propósito de alcanzar la cobertura sanitaria universal, con amplia participación y liderazgo de las organizaciones de base comunitarias más afectadas con un enfoque de equidad de género, igualdad y derechos humanos para acabar con la Tuberculosis y el sida al 2030. / Maximize integrated and people-centered health services with the purpose of achieving universal health coverage, with broad participation and leadership of the most affected community-based organizations with a focus on gender equity, equality and human rights to end Tuberculosis and AIDS by 2030. Objectives: Fortalecer los servicos de prevencion atencion,seguimiento y acompañamiento  de las poblaciones Claves  y personas con VIH en territorios priorizados del pais, basados en el modelo de salud Familiar y Comunitario para el logro de las metas 95-95-95. / Strengthen prevention, care, monitoring and support services for key populations and people with HIV in prioritized territories of the country, based on the Family and Community health model to achieve the 95-95-95 goals; Garantizar servicios de diagnósticos y tratamiento diferenciados y atención de calidad centrados en las personas para mejorar la adherencia al tratamiento de TB y VIH, asegurando la supresión vírica y la curación de TB, en un trabajo coordinado y articulado con las organizaciones y asociaciones debe base comunitaria sin discriminación con equidad de género y derechos humanos evitando la mortalidad temprana y eliminar la transmisión para mejorar calidad de vida y el bienestar de personas con VIH y tuberculosis. /Guarantee differentiated diagnosis and treatment services and quality care centered on people to improve adherence to TB and HIV treatment, ensuring viral suppression and cure of TB, in coordinated and articulated collaboration with community-based organizations and associations. without discrimination with gender equity and human rights, avoiding early mortality and eliminating transmission to improve quality of life and well-being of people living with HIV and tuberculosis; Fortalecer las intervenciones de prevención combinada, integrando los componentes conductuales, biomédicos, estructurales, psicológicos y el abordaje de la salud sexual y reproductiva según necesidades de las poblaciones en mayor riesgo de infección por el VIH y TB, especialmente las poblaciones clave y vulnerables en un trabajo articulado y coordinado con las organizaciones de base comunitaria para mantener a las poblaciones claves libres de VIH y tuberculosis./ Strengthen combined prevention interventions, integrating behavioral, biomedical, structural, psychological components and addressing sexual and reproductive health according to the needs of populations at highest risk of HIV and TB infection, especially key and vulnerable populations in a articulated and coordinated work with community-based organizations to keep key populations free of HIV and tuberculosis; Promover cambios en los programas y las políticas para reducir la estigmatización, la discriminación y las desigualdades relacionados con el VIH y la TB y promover la defensa de los derechos de las personas con VIH y de las poblaciones clave y vulnerables con un enfoque multisectorial con la participación de las Instituciones del estado, las Organizaciones sociales y comunitarias y el sector privado. / Promote changes in programs and policies to reduce stigmatization, discrimination and inequalities related to HIV and TB and promote advocacy for the rights of people with HIV and key and vulnerable populations with a multisectoral approach with participation of state institutions, social and community organizations and the private sector; Promover la generación y la disponibilidad de datos de calidad con interoperabilidad entre las fuentes, centrados en las personas y desglosados. Fiables, oportunos y de calidad en todos los niveles, alineados con los principios de derechos humano para  respaldar el análisis epidemiológico y estratégico de la información y mejorar el desempeño y la calidad de los programas de VIH y TB./ Promote the generation and availability of quality data with interoperability between sources, people-centered and disaggregated. Reliable, timely and quality at all levels, aligned with human rights principles to support the epidemiological and strategic analysis of information and improve the performance and quality of HIV and TB programs.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="24" role="2" crs-channel-code="23000">
      <narrative>Federación Red NICASALUD</narrative>
    </participating-org>
    <participating-org type="24" role="4" crs-channel-code="23000">
      <narrative>Federación Red NICASALUD</narrative>
    </participating-org>
    <other-identifier ref="NIC-C-REDNICAP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2025-01-01" />
    <activity-date type="2" iso-date="2025-01-01" />
    <activity-date type="3" iso-date="2027-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Noemie Restrepo</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>noemie.restrepo@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="NI" percentage="100">
      <narrative>Nicaragua</narrative>
    </recipient-country>
    <sector vocabulary="1" code="13040" percentage="41.29">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="34.17">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="24.54">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="aecf0171-ec0b-4298-be44-3c2a390d7a69" percentage="0.23">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing for KP programs</narrative>
        </description>
      </budget-item>
      <budget-item code="e41c9e1f-dfcd-4d62-9a3d-2c6d760bb3af" percentage="0.53">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing for key population (KP) programs</narrative>
        </description>
      </budget-item>
      <budget-item code="48867067-7709-4cef-94a9-7dcc66211686" percentage="0.24">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing for KP programs</narrative>
        </description>
      </budget-item>
      <budget-item code="fa74be82-0e67-471f-99cd-c36d38ba6843" percentage="0.17">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Early infant diagnosis and follow-up HIV testing for exposed infants</narrative>
        </description>
      </budget-item>
      <budget-item code="7a803e07-8560-47f6-9b59-72193d6812db" percentage="1.7">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Condom and lubricant programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="86dc2898-1dfb-4559-a4cb-72cd5a2cd403" percentage="0.43">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; HIV prevention communication, information and demand creation for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="7300b0bf-fc7f-49ac-b933-534346c226a5" percentage="1.16">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="e14e7a7d-49ce-4bb6-8454-ae4224e7a32e" percentage="2.51">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="d01264fd-1485-4b1a-b85c-fbaa2fa20933" percentage="1.37">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="94dbd87e-0cec-46fb-83f5-7c805de185cb" percentage="1.35">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Condom and lubricant programming for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="3f39233d-f679-42ce-8532-a7949f0d93ef" percentage="1.48">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="daac344e-ec8e-4193-9c8a-266fdd2e69ac" percentage="1.82">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Condom and lubricant programming for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="55ece96e-d30c-46d2-8db0-27306b249434" percentage="0.24">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; HIV prevention communication, information and demand creation for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="ec84ef8b-ad12-46a3-9175-4f68245fa984" percentage="1.48">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="530c3ad4-ec67-412e-9dc9-b83b6de6bf61" percentage="0.4">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Diagnosis and management of advanced HIV disease (adults and children)</narrative>
        </description>
      </budget-item>
      <budget-item code="d49b353e-9087-48e0-9c3b-f8ed91d6fd53" percentage="14.4">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - adults (15 and above)</narrative>
        </description>
      </budget-item>
      <budget-item code="6bb2376e-8c74-4cf1-98f0-f72ea58797fa" percentage="0.05">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - children (under 15)</narrative>
        </description>
      </budget-item>
      <budget-item code="423a40f4-4716-48a1-9c6c-7b78ede223af" percentage="0.4">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Integrated management of common co-infections and co-morbidities (adults and children)</narrative>
        </description>
      </budget-item>
      <budget-item code="75665eb3-7cb7-4083-b197-c97fcbe30044" percentage="11.34">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load and antiretroviral (ARV) toxicity</narrative>
        </description>
      </budget-item>
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="24.69">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="2c341d5c-b46c-47a9-9aff-2700be47f75e" percentage="2.49">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Analyses, evaluations, reviews and data use</narrative>
        </description>
      </budget-item>
      <budget-item code="f94cd008-2af3-49cf-9149-7be7cf0228e7" percentage="6.75">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="cb85db5b-1f59-4c7a-ba74-2cb30ee6a84b" percentage="0.24">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Operational Research</narrative>
        </description>
      </budget-item>
      <budget-item code="ea39b4f6-cd94-4310-b181-394f794f9144" percentage="4.97">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB diagnosis/drug susceptibility testing (DST)</narrative>
        </description>
      </budget-item>
      <budget-item code="5b20da70-c625-405c-858b-6de52626ae46" percentage="3.09">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="f50f08b4-b9d9-4b4a-a8b2-065858f9ce31" percentage="6.21">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB screening and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="003bd5ec-d813-43cd-9bae-ec060870a2c4" percentage="0.21">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="7332ed72-b538-4ab5-b90e-f820e56c0c5b" percentage="0.04">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Infection prevention and control (IPC)</narrative>
        </description>
      </budget-item>
      <budget-item code="897b3d08-9a6f-4d26-89e2-f762e49dad11" percentage="0.46">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Preventive treatment</narrative>
        </description>
      </budget-item>
      <budget-item code="68262ac7-05ab-4aec-9c9e-320d5883c55c" percentage="0.03">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Screening/testing for TB infection</narrative>
        </description>
      </budget-item>
      <budget-item code="8f363382-1b81-4d2d-a396-2be1435016f2" percentage="4.03">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
      <budget-item code="602586f6-9a77-484c-bf39-acc8a3151170" percentage="4.94">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Prevention</narrative>
        </description>
      </budget-item>
      <budget-item code="7c7a7505-bdfe-4146-976c-78a03ca0d545" percentage="0.55">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">2711710.39</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">5605887.94</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2027-01-01" />
      <period-end iso-date="2027-12-31" />
      <value currency="USD" value-date="2027-01-01">4130462.06</value>
    </budget>
    <capital-spend percentage="13.49" />
    <transaction ref="4aa0856d-6310-4096-a2e6-7470b36d8a4b">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-02-06" />
      <value currency="USD" value-date="2025-02-06">6444318.75</value>
      <description>
        <narrative>Global Fund commitment to NIC-C-REDNICAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e9f07d1e-4755-48bc-aefc-8f9550457c23">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-02-11" />
      <value currency="USD" value-date="2025-02-11">823800.00</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c99320ba-a7ca-401b-b5d0-4f71f4d1355f">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-04-22" />
      <value currency="USD" value-date="2025-04-22">852082.11</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8c2ac41e-5f01-43a0-a2df-af2a43609854">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-05-27" />
      <value currency="USD" value-date="2025-05-27">84807.16</value>
      <description>
        <narrative>Global Fund commitment to NIC-C-REDNICAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="79f1b0de-c2c5-4768-8132-8ca3e84e578b">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-02" />
      <value currency="USD" value-date="2025-07-02">163488.17</value>
      <description>
        <narrative>Global Fund commitment to NIC-C-REDNICAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="77e6457d-298c-4b65-ad40-0f51fb44fdc7">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-09-23" />
      <value currency="USD" value-date="2025-09-23">12096.66</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="3d8d1fab-adea-489b-b073-611973757ffb">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-09-30" />
      <value currency="USD" value-date="2025-09-30">829420.13</value>
      <description>
        <narrative>Global Fund commitment to NIC-C-REDNICAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="22d5991b-ef94-4b64-b80b-861b53807dc8">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-21" />
      <value currency="USD" value-date="2025-10-21">759578.67</value>
      <description>
        <narrative>Global Fund commitment to NIC-C-REDNICAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b03f675a-e5da-42b6-b821-45269e9d8f0c">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-21" />
      <value currency="USD" value-date="2025-10-21">-829420.13</value>
      <description>
        <narrative>Global Fund commitment to NIC-C-REDNICAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="74f868e4-698f-4e13-8480-3009dfddc3d6">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-25" />
      <value currency="USD" value-date="2025-11-25">92646.67</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="1d502df3-7d74-4aa4-91e7-cbe50775ce9e">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-09" />
      <value currency="USD" value-date="2025-12-09">11181.43</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3eadf287-699a-456a-8af5-cf999e61ee2b">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-09" />
      <value currency="USD" value-date="2025-12-09">151204.40</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d488ad85-1851-4b23-828f-11b46c63a9ff">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-10" />
      <value currency="USD" value-date="2025-12-10">5119.63</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="cd8a6acf-cacd-4039-b98c-9914e57921b3">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-16" />
      <value currency="USD" value-date="2025-12-16">71147.79</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="4d2a4df8-b46f-451a-bb89-fee3b2a26893">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-02-03" />
      <value currency="USD" value-date="2026-02-03">3552.79</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="5284690e-6153-4826-a925-f28bc42652ab">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-02-03" />
      <value currency="USD" value-date="2026-02-03">71.10</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="893a6705-c0cf-46b3-9cca-dd7a5bf55153">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-02-03" />
      <value currency="USD" value-date="2026-02-03">2480.68</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="68a9b7e6-5eef-4259-8506-153a509ec55b">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-02-03" />
      <value currency="USD" value-date="2026-02-03">14173.68</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="0b703a97-9da5-4502-b183-2f932b1bd9ac">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-02-10" />
      <value currency="USD" value-date="2026-02-10">200694.93</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="f3c38d9d-b716-42f9-8490-b8daddff1136">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-02-24" />
      <value currency="USD" value-date="2026-02-24">1235329.00</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f0e37c4e-244a-48b6-88dc-adb4cedf721e">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-02-24" />
      <value currency="USD" value-date="2026-02-24">136248.04</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="4ba10769-5a6c-4cb2-ace7-dfe2b24e2304">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-03-17" />
      <value currency="USD" value-date="2026-03-17">74633.42</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="41a2f7f5-d5af-48ec-ae35-e516ce91e3e3">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-01" />
      <value currency="USD" value-date="2026-04-01">-33346.96</value>
      <description>
        <narrative>Global Fund commitment to NIC-C-REDNICAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="53ff242c-9fa8-4bfe-bc31-8e923346bff4">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-21" />
      <value currency="USD" value-date="2026-04-21">80989.63</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="bf351d6a-6ce8-485f-a338-e90b00100d5d">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-05-19" />
      <value currency="USD" value-date="2026-05-19">171636.80</value>
      <description>
        <narrative>Global Fund commitment to NIC-C-REDNICAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9101d084-e02a-4252-935c-7fcb5e21b14a">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-06-01" />
      <value currency="USD" value-date="2026-06-01">593.64</value>
      <description>
        <narrative>Funds returned to the Global Fund from NIC-C-REDNICAP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e06107c2-2818-4f9f-8a01-6eeef5e98c71">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-02" />
      <value currency="USD" value-date="2026-06-02">468100.15</value>
      <description>
        <narrative>Global Fund commitment to NIC-C-REDNICAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="50bae6f8-248d-4ed6-853c-e01bf7fb29c1">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-02" />
      <value currency="USD" value-date="2026-06-02">-351487.91</value>
      <description>
        <narrative>Global Fund commitment to NIC-C-REDNICAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8128c145-6bbc-4417-97d0-c3296dc21294">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-05" />
      <value currency="USD" value-date="2026-06-05">-468100.15</value>
      <description>
        <narrative>Global Fund commitment to NIC-C-REDNICAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5fa0f1c6-98cb-40db-8d86-582184fb474b">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-05" />
      <value currency="USD" value-date="2026-06-05">683997.15</value>
      <description>
        <narrative>Global Fund commitment to NIC-C-REDNICAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0e94b079-5c30-4ca8-88bb-bc12b4b1e982">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-08" />
      <value currency="USD" value-date="2026-06-08">-593.64</value>
      <description>
        <narrative>Global Fund commitment to NIC-C-REDNICAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ca22c847-84b7-4588-8439-531d0b470fbc">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-13" />
      <value currency="USD" value-date="2026-06-13">-3817.53</value>
      <description>
        <narrative>Global Fund commitment to NIC-C-REDNICAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fcd6851f-f864-4cbe-ab4b-1f0a7d294651">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-23" />
      <value currency="USD" value-date="2026-06-23">74722.19</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="865c6d12-1537-4292-9f83-35769f704071">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-14" />
      <value currency="USD" value-date="2026-07-14">9760.71</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="16e59953-68e7-46c3-b1f1-91058e9e97b5">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-14" />
      <value currency="USD" value-date="2026-07-14">810376.73</value>
      <description>
        <narrative>Global Fund commitment to NIC-C-REDNICAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8d9571d7-8b59-4a4a-9697-e87cf16bebb0">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-14" />
      <value currency="USD" value-date="2026-07-14">-683997.15</value>
      <description>
        <narrative>Global Fund commitment to NIC-C-REDNICAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1a579402-15c2-4605-be2a-e99da89824db">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-22" />
      <value currency="USD" value-date="2026-07-22">-3211605.49</value>
      <description>
        <narrative>Global Fund commitment to NIC-C-REDNICAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="287f478a-ae54-4d12-9800-25c2f730db46">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-22" />
      <value currency="USD" value-date="2026-07-22">3597833.56</value>
      <description>
        <narrative>Global Fund commitment to NIC-C-REDNICAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="37267757-113f-4de3-a04a-ba56c6cd14b0">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-28" />
      <value currency="USD" value-date="2026-07-28">111594.00</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="b0c2a657-4acd-4eac-bf4d-b0de6a91954f">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-04" />
      <value currency="USD" value-date="2026-08-04">83448.12</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="32b56496-c734-4341-b68a-71c74b8ec154">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-11" />
      <value currency="USD" value-date="2026-08-11">1540909.92</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="535d64df-62ec-4add-8538-f0d3d315fca1">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-18" />
      <value currency="USD" value-date="2026-08-18">330203.60</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="396e3e0e-c52f-4530-8bee-d1cebdb30ee3">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-18" />
      <value currency="USD" value-date="2026-08-18">240706.64</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b2ee6942-78bd-448d-9d28-7a8be5739558">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-09-01" />
      <value currency="USD" value-date="2026-09-01">-171636.80</value>
      <description>
        <narrative>Global Fund commitment to NIC-C-REDNICAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="39e93edf-8c01-4c1e-8d2e-50d39d95d87c">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-09-01" />
      <value currency="USD" value-date="2026-09-01">229833.17</value>
      <description>
        <narrative>Global Fund commitment to NIC-C-REDNICAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bfdaa409-990c-42bb-9957-daadf5d5add2">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-09-23" />
      <value currency="USD" value-date="2026-09-23">367466.26</value>
      <description>
        <narrative>Global Fund commitment to NIC-C-REDNICAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f53d845e-1c01-4aa1-9caf-51f555bf5a34">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-09-23" />
      <value currency="USD" value-date="2026-09-23">-285131.01</value>
      <description>
        <narrative>Global Fund commitment to NIC-C-REDNICAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8fe4971e-c5a9-4470-9b76-c440c8862c2b">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-09-26" />
      <value currency="USD" value-date="2026-09-26">367867.59</value>
      <description>
        <narrative>Global Fund commitment to NIC-C-REDNICAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5a48befa-bb08-4ed1-bca3-d53eb09cf9d4">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-06" />
      <value currency="USD" value-date="2026-10-06">25413.92</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="4a7c17d1-db17-46c6-8fa5-276e9bba04c4">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-06" />
      <value currency="USD" value-date="2026-10-06">63935.07</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0f7b522e-e175-410f-9c1e-3ebdc9acc2ed">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-10-08" />
      <value currency="USD" value-date="2026-10-08">6635.19</value>
      <description>
        <narrative>Funds returned to the Global Fund from NIC-C-REDNICAP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4287004e-ba1c-4898-8c94-28798842eaf7">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-08" />
      <value currency="USD" value-date="2026-10-08">337034.10</value>
      <description>
        <narrative>Global Fund commitment to NIC-C-REDNICAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6fd006a1-dd05-4651-9ef3-9a22b16434e3">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-08" />
      <value currency="USD" value-date="2026-10-08">-342052.34</value>
      <description>
        <narrative>Global Fund commitment to NIC-C-REDNICAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d6aebe6e-31d8-4b7c-bde6-b161b2581e9e">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-13" />
      <value currency="USD" value-date="2026-10-13">117327.63</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="e230e9b3-0b68-4d36-ae9b-cbb8663daba8">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-13" />
      <value currency="USD" value-date="2026-10-13">86200.99</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="3569013c-1430-4e96-bfff-d0f5badad96a">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-15" />
      <value currency="USD" value-date="2026-10-15">-6635.19</value>
      <description>
        <narrative>Global Fund commitment to NIC-C-REDNICAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f673d59d-fe89-4064-82bc-eedcfc290057">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-16" />
      <value currency="USD" value-date="2026-10-16">-250833.11</value>
      <description>
        <narrative>Global Fund commitment to NIC-C-REDNICAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3ea44540-a58b-44d1-8717-9b6e4b3ca2f0">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-16" />
      <value currency="USD" value-date="2026-10-16">229548.80</value>
      <description>
        <narrative>Global Fund commitment to NIC-C-REDNICAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="19930fc3-5538-4740-80cb-62f921498556">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-20" />
      <value currency="USD" value-date="2026-10-20">5474.77</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="36e4d008-9194-4302-aa95-4a83a58e2956">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-22" />
      <value currency="USD" value-date="2026-10-22">-367867.59</value>
      <description>
        <narrative>Global Fund commitment to NIC-C-REDNICAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="427c15d5-edb6-4de9-b9b5-e85e8d5cc5bf">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-22" />
      <value currency="USD" value-date="2026-10-22">377552.66</value>
      <description>
        <narrative>Global Fund commitment to NIC-C-REDNICAP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fad593ed-b48e-4d63-9848-588fea3a262e">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-11-03" />
      <value currency="USD" value-date="2026-11-03">19042.42</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="381e8a24-e175-416e-ba4c-f5236b9120a2">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-11-10" />
      <value currency="USD" value-date="2026-11-10">1962.82</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="ec0bdadd-17a6-4514-9720-3e62902d46c0">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-11-10" />
      <value currency="USD" value-date="2026-11-10">75201.73</value>
      <description>
        <narrative>Global Fund disbursement to NIC-C-REDNICAP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="NIC-C-REDNICAP01-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">1717965.23</value>
      <description>
        <narrative>Expenditure reported by Federación Red NICASALUD for NIC-C-REDNICAP01, Jan 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Federación Red NICASALUD</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/NIC-C-REDNICA" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-12" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/NIC/2024/TB_HIV/en/NIC-C_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2024 - Funding Request - Window 5 - TB/HIV - Nicaragua - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1663-NIC-C.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2024-04-29" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/NIC/2024/TB_HIV/es/NIC-C_FundingRequest_1_es.zip" format="application/zip">
      <title>
        <narrative>2024 - Funding Request - Window 5 - TB/HIV - Nicaragua - Español</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1663-NIC-C.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="es" />
      <document-date iso-date="2024-04-29" />
    </document-link>
    <conditions attached="1">
      <condition type="1">
        <narrative>1 - Personal Data (1) Principles. The Principal Recipient, acknowledges that Program Activities are expected to respect the following principles and rights (“Data Protection Principles”): (a) Information that could be used to identify a natural person (“Personal Data”) will be: (i) processed lawfully, fairly and transparently; (ii) collected for specified, explicit and legitimate purposes and not further processed in a manner not compatible with those purposes;  (iii) adequate, relevant and limited to what is necessary for the purposes for which they are processed; (iv) accurate and, where necessary, kept up to date; (v) kept in a form which permits identification of the individuals for no longer than is necessary for the purposes for which the Personal Data is processed; and (vi) processed in a manner that ensures appropriate security of the Personal Data; and (b) Natural persons are afforded, where relevant, the right to information about Personal Data that is processed; the right to access and rectify or erase Personal Data; the right to data portability; the right to confidentiality of electronic communications; and the right to object to processing. (2) Limitations. Where collection and processing of Personal Data is required in order to implement Program Activities, whether by the Principal Recipient, a Sub-recipient, or Supplier, the Principal Recipient should respect the Data Protection Principles: (a) to the extent that doing so does not violate or conflict with applicable law and/or policy; and (b) subject to the Principal Recipient balancing the Data Protection Principles with other fundamental rights in accordance with the principle of proportionality, taking into account the risks to the rights and freedoms of natural persons.</narrative>
      </condition>
      <condition type="1">
        <narrative>2 - With respect to Section 7.6 (Right of Access) of the Global Fund Grant Regulations (as amended from time to time), (1) the Global Fund may collect or seek to collect data, and it is possible that such data may contain Personal Data, and (2), prior to collection and at all times thereafter, the Principal Recipient shall take all necessary actions to ensure that the transfer of such information to the Global Fund does not violate any applicable law or regulation.</narrative>
      </condition>
      <condition type="3">
        <narrative>4 - The procurement of Health Products shall be carried out through the Pooled Procurement Mechanism (“PPM”) of the Global Fund, unless the Global Fund directs the Principal Recipient otherwise in writing. The Principal Recipient has all the necessary power and authority to execute, deliver and carry out its obligations under the wambo.org – PPM registration letter in the form approved by the Global Fund.</narrative>
      </condition>
      <condition type="2">
        <narrative>6 - Prior to the use of Grant Funds of up to USD 454,136 by the Principal Recipient to finance any budget lines approved in cost category 9.4 of the detailed budget, (Maintenance and service costs non-health equipment), the Principal Recipient shall submit to the Global Fund, and obtain the Global Fund’s approval of, a fixed asset review report, a cost-benefit analysis report, distribution plan and any other supporting documents.</narrative>
      </condition>
    </conditions>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="48.82">
          <comment>
            <narrative>Numerator: 18127; Denominator: 37129.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="70">
            <comment>
              <narrative>Numerator: 25697; Denominator: 36710.</narrative>
            </comment>
          </target>
          <actual value="35.79">
            <comment>
              <narrative>Numerator: 13138; Denominator: 36710.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="75.25">
            <comment>
              <narrative>Numerator: 27658; Denominator: 36757.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 29454; Denominator: 36818.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of TG that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of TG that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="50.34">
          <comment>
            <narrative>Numerator: 2588; Denominator: 5141.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="58">
            <comment>
              <narrative>Numerator: 3185; Denominator: 5491.</narrative>
            </comment>
          </target>
          <actual value="21.07">
            <comment>
              <narrative>Numerator: 1157; Denominator: 5491.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="61.99">
            <comment>
              <narrative>Numerator: 3412; Denominator: 5504.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="66">
            <comment>
              <narrative>Numerator: 3642; Denominator: 5518.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="67.53">
          <comment>
            <narrative>Numerator: 11819; Denominator: 17501.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="66">
            <comment>
              <narrative>Numerator: 12133; Denominator: 18384.</narrative>
            </comment>
          </target>
          <actual value="36.17">
            <comment>
              <narrative>Numerator: 6649; Denominator: 18384.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="69">
            <comment>
              <narrative>Numerator: 12858; Denominator: 18635.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="70">
            <comment>
              <narrative>Numerator: 13226; Denominator: 18894.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="35" />
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="66" />
          <actual value="32" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="73" />
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="79" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="71.43">
          <comment>
            <narrative>Numerator: 25; Denominator: 35.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="84.85">
            <comment>
              <narrative>Numerator: 56; Denominator: 66.</narrative>
            </comment>
          </target>
          <actual value="78.13">
            <comment>
              <narrative>Numerator: 25; Denominator: 32.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="89.04">
            <comment>
              <narrative>Numerator: 65; Denominator: 73.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="91.14">
            <comment>
              <narrative>Numerator: 72; Denominator: 79.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="85.71">
          <comment>
            <narrative>Numerator: 24; Denominator: 28.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="88">
            <comment>
              <narrative>Numerator: 22; Denominator: 25.</narrative>
            </comment>
          </target>
          <actual value="72.5">
            <comment>
              <narrative>Numerator: 29; Denominator: 40.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="88.57">
            <comment>
              <narrative>Numerator: 31; Denominator: 35.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="91.07">
            <comment>
              <narrative>Numerator: 51; Denominator: 56.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of MSM who received any PrEP product at least once during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for men who have sex with men (MSM) and their sexual partners.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of MSM who received any PrEP product at least once during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="187" />
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="1117" />
          <actual value="455" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="2084" />
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="2550" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for men who have sex with men (MSM) and their sexual partners.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="49.36">
          <comment>
            <narrative>Numerator: 18328; Denominator: 37129.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="51">
            <comment>
              <narrative>Numerator: 18722; Denominator: 36710.</narrative>
            </comment>
          </target>
          <actual value="35.79">
            <comment>
              <narrative>Numerator: 13138; Denominator: 36710.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="55">
            <comment>
              <narrative>Numerator: 20216; Denominator: 36757.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="58">
            <comment>
              <narrative>Numerator: 21354; Denominator: 36818.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of sex workers who received any PrEP product at least once during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for sex workers, their clients and other sexual partners.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of sex workers who received any PrEP product at least once during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="0" />
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="70" />
          <actual value="23" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="95" />
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="124" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for sex workers, their clients and other sexual partners.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="30.5">
          <comment>
            <narrative>Numerator: 5338; Denominator: 17501.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="36">
            <comment>
              <narrative>Numerator: 6618; Denominator: 18384.</narrative>
            </comment>
          </target>
          <actual value="36.17">
            <comment>
              <narrative>Numerator: 6649; Denominator: 18384.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="39">
            <comment>
              <narrative>Numerator: 7268; Denominator: 18635.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="42">
            <comment>
              <narrative>Numerator: 7935; Denominator: 18894.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of transgender people who received any PrEP product at least once during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for transgender people and their sexual partners.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of transgender people who received any PrEP product at least once during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="7" />
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="73" />
          <actual value="17" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="144" />
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="263" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of transgender people reached with HIV prevention programs - defined package of services</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for transgender people and their sexual partners.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of transgender people reached with HIV prevention programs - defined package of services</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="25.11">
          <comment>
            <narrative>Numerator: 1291; Denominator: 5141.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="25">
            <comment>
              <narrative>Numerator: 1373; Denominator: 5491.</narrative>
            </comment>
          </target>
          <actual value="21.07">
            <comment>
              <narrative>Numerator: 1157; Denominator: 5491.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="30">
            <comment>
              <narrative>Numerator: 1651; Denominator: 5504.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="34.99">
            <comment>
              <narrative>Numerator: 1931; Denominator: 5518.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="2122" />
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="2592" />
          <actual value="2579" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="2632" />
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="2671" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="56.46">
          <comment>
            <narrative>Numerator: 1198; Denominator: 2122.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="65.01">
            <comment>
              <narrative>Numerator: 1685; Denominator: 2592.</narrative>
            </comment>
          </target>
          <actual value="51.18">
            <comment>
              <narrative>Numerator: 1320; Denominator: 2579.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="69.98">
            <comment>
              <narrative>Numerator: 1842; Denominator: 2632.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="74.99">
            <comment>
              <narrative>Numerator: 2003; Denominator: 2671.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="86.49">
          <comment>
            <narrative>Numerator: 1818; Denominator: 2102.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="88.01">
            <comment>
              <narrative>Numerator: 2247; Denominator: 2553.</narrative>
            </comment>
          </target>
          <actual value="84.33">
            <comment>
              <narrative>Numerator: 1910; Denominator: 2265.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="89">
            <comment>
              <narrative>Numerator: 2307; Denominator: 2592.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="90.01">
            <comment>
              <narrative>Numerator: 2369; Denominator: 2632.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB/DR-TB Prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="2555" />
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="2736" />
          <actual value="975" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="3518" />
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="4322" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="97.28">
          <comment>
            <narrative>Numerator: 143; Denominator: 147.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="97.48">
            <comment>
              <narrative>Numerator: 155; Denominator: 159.</narrative>
            </comment>
          </target>
          <actual value="93.43">
            <comment>
              <narrative>Numerator: 185; Denominator: 198.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="97.53">
            <comment>
              <narrative>Numerator: 158; Denominator: 162.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="97.58">
            <comment>
              <narrative>Numerator: 161; Denominator: 165.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="50.89">
          <comment>
            <narrative>Numerator: 712; Denominator: 1399.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="9.66">
            <comment>
              <narrative>Numerator: 860; Denominator: 8904.</narrative>
            </comment>
          </target>
          <actual value="9.02">
            <comment>
              <narrative>Numerator: 750; Denominator: 8315.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="9.57">
            <comment>
              <narrative>Numerator: 933; Denominator: 9754.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="9.59">
            <comment>
              <narrative>Numerator: 1012; Denominator: 10554.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="59.93">
          <comment>
            <narrative>Numerator: 7204; Denominator: 12021.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="71.95">
            <comment>
              <narrative>Numerator: 8904; Denominator: 12375.</narrative>
            </comment>
          </target>
          <actual value="67.19">
            <comment>
              <narrative>Numerator: 8315; Denominator: 12375.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="77.57">
            <comment>
              <narrative>Numerator: 9754; Denominator: 12575.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="82.85">
            <comment>
              <narrative>Numerator: 10554; Denominator: 12738.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>